Mumbai (Maharashtra) [India], Aug 10 (ANI): India Ratings and Research (Ind-Ra) said on Tuesday that 13.7 per cent y-o-y revenue growth in India's pharmaceutical market during 2021 was led by continued demand normalisation post the high growth months of April and May.